Development of population pharmacokinetics model and Bayesian estimation of rifampicin exposure in Indonesian patients with tuberculosis - 10/03/23
, Rannissa Puspita Jayanti e, f, 1, Ni Made Mertaniasih c, d, g, Tutik Kusmiati a, c, d, Ariani Permatasari a, c, d, Dwi Wahyu Indrawanto a, d, Anita Nur Charisma a, d, Elvina Elizabeth Lius a, d, Rika Yuliwulandari h, i, Pham Quang Hoa e, f, Nguyen Ky Phat e, f, Vo Thuy Anh Thu e, Nguyen Ky Anh e, f, Sangzin Ahn e, f, Nguyen Phuoc Long e, f, Yong-Soon Cho e, f, ⁎ , Jae-Gook Shin e, f, jAbstract |
Background |
Interindividual variability in the pharmacokinetics (PK) of anti-tuberculosis (TB) drugs is the leading cause of treatment failure. Herein, we evaluated the influence of demographic, clinical, and genetic factors that cause variability in RIF PK parameters in Indonesian TB patients.
Methods |
In total, 210 Indonesian patients with TB (300 plasma samples) were enrolled in this study. Clinical data, solute carrier organic anion transporter family member-1B1 (SLCO1B1) haplotypes *1a, *1b, and *15, and RIF concentrations were analyzed. The population PK model was developed using a non-linear mixed effect method.
Results |
A one-compartment model with allometric scaling adequately described the PK of RIF. Age and SLCO1B1 haplotype *15 were significantly associated with variability in apparent clearance (CL/F). For patients in their 40s, each 10-year increase in age was associated with a 10% decrease in CL/F (7.85 L/h). Patients with the SLCO1B1 haplotype *15 had a 24% lower CL/F compared to those with the wild-type. Visual predictive checks and non-parametric bootstrap analysis indicated good model performance.
Conclusion |
Age and SLCO1B1 haplotype *15 were significant covariates of RIF CL/F. Geriatric patients with haplotype *15 had significantly greater exposure to RIF. The model could optimize TB pharmacotherapy through its application in therapeutic drug monitoring (clinical trial no. NCT05280886).
Le texte complet de cet article est disponible en PDF.Highlights |
• | LBW, age, and SLCO1B1 *15 were significantly associated with RIF PK variability. |
• | Geriatric Indonesian TB patients had high exposure of RIF. |
• | Sparse sampling at random post-dose time points enables good estimation of RIF PK. |
• | SLCO1B1 *15 haplotype was associated with 24% lower clearance of RIF. |
Keywords : Tuberculosis, Rifampicin, Pharmacogenetic, Population pharmacokinetics, Therapeutic drug monitoring
Plan
Vol 139
Article 102325- mars 2023 Retour au numéro
Article précédent
- Clinical, histopathological, and molecular findings for Mycobacterium avium subspecies paratuberculosis (MAP) in dairy goats under semiarid conditions
- João Paulo de Lacerda Roberto, Clécio Henrique Limeira, João Pessoa Araújo Júnior, Camila Dantas Malossi, Leila Sabrina Ullmann, Maria Luana Cristiny Rodrigues Silva, Antônio Flavio Medeiros Dantas, Maria Jussara Rodrigues do Nascimento, Sergio Santos de Azevedo, Clebert José Alves
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?